Ellagic acid formulations for use in coagulation assays
US10746749B2 · kind B2 · utility
2Cited by
61References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 6, 2018 |
| Grant date | Aug 18, 2020 |
| Priority date | — |
| Expiry date | Jul 14, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/974
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to ellagic acid formulations for performing coagulation assays that are highly stable for long term storage and reduce assay time. Particularly, aspects of the present invention are directed to a composition and method of preparing ellagic acid in a highly soluble format for use in a coagulation assay. For example, the ellagic acid may be solubilized in one or more of sodium hydroxide, methanol, a polyether compound, particularly polyethylene glycol, polyethylene oxide, or polyoxyethylene, and a cyclodextrin guest-host complex.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.